MODUPE ADERIBIGBE, D.P.M.
Primary Podiatric Medicine Podiatrist in SAINT LOUIS, Missouri. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MODUPE ADERIBIGBE, D.P.M. filed 598 Medicare Part D claims in 2023 as a Primary Podiatric Medicine Podiatrist in SAINT LOUIS, Missouri, prescribing 98% generic.
- 598
- Part D claims, 2023
- 98%
- generic prescribing
- $15.71
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MODUPE ADERIBIGBE, D.P.M.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
598 Top 34% higher than 66% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about MODUPE ADERIBIGBE, D.P.M.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Missouri
How Primary Podiatric Medicine Podiatrist compares to other specialties among Missouri providers
Primary Podiatric Medicine Podiatrist share within Missouri
Primary Podiatric Medicine Podiatrist is one of the more visible NUCC categories in Missouri
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Primary Podiatric Medicine Podiatrist (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Primary Podiatric Medicine Podiatrist ABMS/AOA estimate
Est. board-certified rate (Primary Podiatric Medicine Podiatrist) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Primary Podiatric Medicine Podiatrist US NPIs
Specialty board-certified rate — Primary Podiatric Medicine Podiatrist estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MODUPE ADERIBIGBE, D.P.M. appears in the CMS NPPES registry as a Primary Podiatric Medicine Podiatrist provider holding D.P.M. credentials at 5471 DR MARTIN LUTHER KING DR, SAINT LOUIS, MO, 63112, with a listed phone of (314) 367-5820. NPI 1407092927 was issued on 01/06/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ADERIBIGBE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 598 prescription claims written by this provider, covering 161 Medicare beneficiaries and totaling roughly $23K in drug spend, split 2% brand-name and 98% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Primary Podiatric Medicine Podiatrist is a narrow specialty nationwide, with 1,077 enrolled providers across 50 states and an average of 322 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1407092927 |
|---|---|
| Specialty | Primary Podiatric Medicine Podiatrist |
| Credentials | D.P.M. |
| Gender | Female |
| NPI Issued | 01/06/2009 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MODUPE ADERIBIGBE, D.P.M.'s current license status, disciplinary history, and board certifications with the Missouri Board of Registration for the Healing Arts in Missouri before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where MODUPE ADERIBIGBE, D.P.M. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MODUPE ADERIBIGBE, D.P.M.. Source: openpaymentsdata.cms.gov.
Total received
$16
Largest payer
MIMEDX Group, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
2% brand-name claims vs 98% generic, on 598 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 681
- Total Day Supply
- 18,892
- Brand vs Generic
- 2% brand / 98% generic
- Brand Drug Cost
- $6K
- Generic Drug Cost
- $17K
- Antibiotic Claims
- 18
Patient Demographics
- Average Patient Age
- 66.7 years
- Avg HCC Risk Score
- 2.22
- Gender Split
- 63% female / 37% male
- Age Distribution
- <65: 59, 65-74: 69, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MODUPE ADERIBIGBE, D.P.M. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Ammonium Lactate
Ammonium Lactate
181 claims
- Gabapentin 64
Gabapentin
64 claims
- Diclofenac Sodium 62
Diclofenac Sodium
62 claims
- Pregabalin 51
Pregabalin
51 claims
- Clotrimazole 43
Clotrimazole
43 claims
- Ciclopirox 31
Ciclopirox
31 claims
- Terbinafine Hcl 31
Terbinafine Hcl
31 claims
- Clotrimazole-Betam… 29
Clotrimazole-Betamethasone
29 claims
| Drug | Claims |
|---|---|
| Ammonium Lactate | 181 |
| Gabapentin | 64 |
| Diclofenac Sodium | 62 |
| Pregabalin | 51 |
| Clotrimazole | 43 |
| Ciclopirox | 31 |
| Terbinafine Hcl | 31 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 29 |
| Duloxetine Hcl | 11 |
| Meloxicam | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Primary Podiatric Medicine Podiatrist Overview
How MODUPE ADERIBIGBE, D.P.M. fits within the Primary Podiatric Medicine Podiatrist landscape nationally.
MODUPE ADERIBIGBE, D.P.M.'s 598 claims are above the specialty average of 322.
Nearby Primary Podiatric Medicine Podiatrist Providers in Missouri
Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as ADERIBIGBE.
Compare Primary Podiatric Medicine Podiatrist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Missouri
Frequently Asked Questions
What is MODUPE ADERIBIGBE, D.P.M.'s specialty? ▼
How much does MODUPE ADERIBIGBE, D.P.M. prescribe under Medicare Part D? ▼
Where is MODUPE ADERIBIGBE, D.P.M. located? ▼
What is MODUPE ADERIBIGBE, D.P.M.'s NPI number? ▼
Does MODUPE ADERIBIGBE, D.P.M. prescribe more brand-name or generic drugs? ▼
How many Primary Podiatric Medicine Podiatrist providers are there in the US? ▼
What drugs does MODUPE ADERIBIGBE, D.P.M. prescribe most often? ▼
Does MODUPE ADERIBIGBE, D.P.M. accept Medicare? ▼
How can I verify MODUPE ADERIBIGBE, D.P.M.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology